Form S-8

As filed with the Securities and Exchange Commission on March 31, 2009.

Registration No. 333-            

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

 

Covidien Ltd.

(Exact name of registrant as specified in its charter)

 

Bermuda   98-0518045
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

131 Front Street, Hamilton, HM 12, Bermuda

(Address of Principal Executive Offices)

Covidien Ltd. 2007 Stock and Incentive Plan (as amended and restated)

(Full title of the plan)

John H. Masterson

Senior Vice President and General Counsel

Covidien

15 Hampshire Street, Mansfield, Massachusetts 02048

(Name and address of agent for service)

(508) 261-8000

(Telephone number, including area code, of agent for service)

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer x   Accelerated filer ¨
Non-accelerated filer ¨   Smaller reporting company ¨
(do not check if smaller reporting company)  

CALCULATION OF REGISTRATION FEE

 

 

Title of Securities

to be

Registered

 

Amount

to be

Registered (1)

 

Proposed

Maximum

Offering

Price Per

Share (2)

 

Proposed

Maximum

Aggregate

Offering

Price (2)

 

Amount of

Registration

Fee (2)

Common Shares, $0.20 par value per share

  24,002,521   $33.15   $795,683,572   $44,400
 
 

 

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, this registration statement also registers such additional Common Shares that become available under the foregoing plan in connection with changes in the number of outstanding Common Shares because of events such as recapitalizations, stock dividends, stock splits and reverse stock splits, and any other securities with respect to which the outstanding shares are converted or exchanged.

 

(2) Estimated solely for the purpose of calculating the registration fee. This registration fee has been calculated pursuant to Rule 457(c) and Rule 457(h)(1) of the Securities Act of 1933, as amended, based upon the average of the high and low prices of Covidien Ltd.’s Common Shares, par value $0.20 per share, on March 26, 2009, as reported by the New York Stock Exchange, which was $33.15.


EXPLANATORY NOTE

This registration statement is filed for the purpose of registering 24,002,521common shares (the “Common Stock”) of Covidien Ltd. (the “Company”) issuable pursuant to the Company’s amended and restated 2007 Stock and Incentive Plan (the “Amended Plan”), which Common Stock is in addition to the 24,843,452 shares of Common Stock currently registered on the Company’s registration statement on Form S-8 filed on July 3, 2007 (File No. 333-144309) (the “Prior Registration Statement”). This registration statement relates to the securities of the same class as those to which the Prior Registration Statement relates, and is submitted in accordance with General Instruction E to Form S-8 regarding registration of additional securities. Pursuant to Instruction E to Form S-8, this registration statement incorporates by reference the Prior Registration Statement, to the extent not modified by this registration statement.

 

ITEM 8. EXHIBITS

 

Exhibit No.

  

Description

  5.1    Opinion of counsel
23.1    Consent of Independent Registered Public Accounting Firm
23.2    Consent of counsel (included in Exhibit 5.1)
24.1    Power of Attorney


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Covidien certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Mansfield, Commonwealth of Massachusetts, on this 31st day of March, 2009.

 

COVIDIEN LTD.

(Registrant)

By:                 *
 

Richard J. Meelia

Chairman, President and Chief Executive Officer

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the date indicated.

 

Name

  

Title

  

Date

*

Richard J. Meelia

   Chairman, President and Chief Executive Officer
(principal executive officer)
   March 31, 2009

*

Charles J. Dockendorff

   Executive Vice President and Chief Financial Officer
(principal financial officer)
   March 31, 2009

*

Richard G. Brown, Jr.

   Vice President, Chief Accounting Officer and Controller
(principal accounting officer)
   March 31, 2009

*

Richard J. Meelia

   Authorized Representative in the United States    March 31, 2009

*

Dennis H. Reilley

   Director    March 31, 2009

*

Craig Arnold

   Director    March 31, 2009

*

Robert H. Brust

   Director    March 31, 2009

*

John M. Connors, Jr.

   Director    March 31, 2009

*

Christopher J. Coughlin

   Director    March 31, 2009


Name

  

Title

  

Date

*

Timothy M. Donahue

   Director    March 31, 2009

*

Kathy J. Herbert

   Director    March 31, 2009

*

Randall J. Hogan, III

   Director    March 31, 2009

*

Tadataka Yamada

   Director    March 31, 2009

*

Joseph A. Zaccagnino

   Director    March 31, 2009

A Majority of the Board of Directors.

 

* The undersigned does hereby sign this Registration Statement on behalf of the above indicated individual pursuant to a power of attorney executed by such individual.

 

By:           /s/ John H. Masterson
 

John H. Masterson

Attorney-in-Fact


EXHIBIT INDEX

 

Exhibit No.

  

Description

  5.1    Opinion of counsel
23.1    Consent of Independent Registered Public Accounting Firm
23.2    Consent of counsel (included in Exhibit 5.1)
24.1    Power of Attorney